Advarra
7
0
1
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
1 terminated/withdrawn out of 7 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Fuzzle System for Appetite Control and Weight Management
Role: collaborator
Using a Novel Skin Tag Removal Device
Role: collaborator
A Study Comparing Immediate Treatment to Deferred Treatment With the Fisher Wallace (FW) Stimulator FW-200 Device for the Treatment of Self-reported Anxiety in First Responders
Role: collaborator
Exploratory Study for Toivoa-001 on Human Factors
Role: collaborator
Investigating Immune Escape by SARS-CoV-2 Variants
Role: collaborator
Evaluation of PerioMonitor for Detection of Oral Inflammatory Load (OIL) in Human Subjects.
Role: collaborator
Electronic Consultation for AD/ADRD Residents Experiencing Infectious Diseases
Role: collaborator
All 7 trials loaded